Get the Stockscreener App
3.40
1.19%
0.04
After Hours:
3.91
0.51
+15.00%
Vaccinex Inc stock is traded at $3.40, with a volume of 52,430.
It is up +1.19% in the last 24 hours and down -40.66% over the past month.
Vaccinex Inc is pioneering a differentiated approach to treating cancer and slowly progressive neurodegenerative diseases through the inhibition of semaphorin 4D (SEMA4D). The company's lead drug candidate, pepinemab, blocks SEMA4D, a potent biological effector that it believes prevents immune infiltration into tumors and triggers inflammation in chronic diseases of the brain. Pepinemab is being evaluated in a Phase 1b/2 study in recurrent or metastatic head and neck cancer and in a Phase 1/2a study in Alzheimer's Disease, with ongoing exploration of potential Phase 3 development in Huntington's disease. The firm has also developed a proprietary drug discovery platform, ActivMAb.
See More
Previous Close:
$3.36
Open:
$3.62
24h Volume:
52,430
Relative Volume:
0.68
Market Cap:
$6.05M
Revenue:
-
Net Income/Loss:
$-22.01M
P/E Ratio:
-0.5152
EPS:
-6.6
Net Cash Flow:
$-18.31M
1W Performance:
-24.28%
1M Performance:
-40.66%
6M Performance:
-54.12%
1Y Performance:
-78.51%
1-Day Range:
$3.39
$4.1799
1-Week Range:
$3.18
$4.68
52-Week Range:
$3.18
$18.06
Vaccinex Inc Stock (VCNX) Company Profile
Name
Vaccinex Inc
Sector
Industry
Phone
585-271-2700
Address
1895 MOUNT HOPE AVE, ROCHESTER, NY
Vaccinex Inc Stock (VCNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-23-20 | Downgrade | BTIG Research | Buy → Neutral |
| Sep-04-18 | Initiated | Ladenburg Thalmann | Buy |
Vaccinex Inc Stock (VCNX) Latest News
VSME’s price-to-free cash flow ratio: What it means for investors - US Post News
Vaccinex stock hits 52-week low at $4.17 amid sharp annual decline - Investing.com
Short Interest in Victory Square Technologies Inc. (OTCMKTS:VSQTF) Declines By 79.4% - Defense World
Vaccinex stock hits 52-week low at $4.17 amid sharp annual decline - Investing.com UK
Viemed Healthcare, Inc. (NASDAQ:VMD) Shares Purchased by Victory Capital Management Inc. - Defense World
WUXI BIO Buys back ~3.32M Shrs for ~$42.55M Ytd - AASTOCKS.com
Vaxcyte Inc (PCVX) receives a Buy rating from Mizuho - Knox Daily
Victrex plc (LON:VCT) Insider Jane Toogood Acquires 508 Shares - MarketBeat
Victrex Director Buys Shares, Signals Confidence - TipRanks
Bank of New York Mellon Corp Boosts Stock Holdings in Viemed Healthcare, Inc. (NASDAQ:VMD) - Defense World
StockNews.com Initiates Coverage on Vector Group (NYSE:VGR) - Defense World
VICR Investors Have Opportunity to Lead Vicor Corporation Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
The Gross Law Firm Reminds Vicor Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 23, 2024VICR - PR Newswire
Victory Capital Management Inc. Has $496,000 Stock Holdings in Zymeworks Inc. (NYSE:ZYME) - Defense World
Rhumbline Advisers Has $1.01 Million Position in V2X, Inc. (NYSE:VVX) - Defense World
Choreo LLC Takes Position in Vector Group Ltd. (NYSE:VGR) - Defense World
VICOR 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Vicor CorporationVICR - Business Wire
VICR FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, - GlobeNewswire
First Eagle Investment Management LLC Purchases 2,067 Shares of V2X, Inc. (NYSE:VVX) - Defense World
Vaccinex issues new warrants, secures $6.2 million in funding - Investing.com
Vaccinex issues new warrants, secures $6.2 million in funding - Investing.com India
Victory Capital Management Inc. Cuts Stake in Wyndham Hotels & Resorts, Inc. (NYSE:WH) - Defense World
Vaccinex secures $6.2 million through warrant exercises By Investing.com - Investing.com Canada
What's Going On With Vaccinex Stock Wednesday? - Benzinga
Vaccinex secures $6.2 million through warrant exercises - Investing.com India
Vaccinex secures $6.2 million through warrant exercises By Investing.com - Investing.com Australia
Vaccinex secures $6.2 million through warrant exercises - Investing.com
Vaccinex secures $6.2 million through warrant exercises By Investing.com - Investing.com UK
Vaccinex Announces Exercise of Warrants for $6.2 Million in Gross Proceeds - GlobeNewswire
Vaccinex Announces Exercise of Warrants for $6.2 Million in Gross Proceeds - StockTitan
(VCNX) Investment Report - Stock Traders Daily
Vaccinex, Inc. (NASDAQ:VCNX) Sees Large Decline in Short Interest - Defense World
Vaccinex Director Chrystyna Bedrij Stecyk Abruptly Resigns - TipRanks
Vaccinex announces warrant cancellation option - Investing.com India
Vaccinex announces warrant cancellation option By Investing.com - Investing.com Canada
Vaccinex announces warrant cancellation option By Investing.com - Investing.com UK
Vaccinex (VCNX) Extends Rally With New Clinical Insights - Stocks Telegraph
VCNX (Vaccinex) Short-Term Debt & Capital Lease Obligation : $0.18 Mil (As of Mar. 2024) - GuruFocus.com
VCNX (Vaccinex) Cash Flow for Lease Financing : $0.00 Mil (TTM As of Mar. 2024) - GuruFocus.com
Vaccinex (NASDAQ:VCNX) Issues Earnings Results - Defense World
Vaccinex Provides Update on New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab in Alzheimer’s Disease and Plans to Pursue a Development Partnership - Markets Insider
Vaccinex reports promising Alzheimer's drug results - Investing.com
Vaccinex reports promising Alzheimer's drug results By Investing.com - Investing.com Canada
Vaccinex reports promising Alzheimer's drug results By Investing.com - Investing.com Australia
Vaccinex Provides Update on Alzheimer’s Treatment Trial - TipRanks
Vaccinex reports promising Alzheimer's drug results By Investing.com - Investing.com UK
Vaccinex Provides Update on New Findings for SIGNAL-AD - GlobeNewswire
Vaccinex Provides Update on New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab in Alzheimer’s Disease and Plans to Pursue a Development Partnership - StockTitan
Albert Friedberg Acquires 3,653 Shares of Vaccinex, Inc. (NASDAQ:VCNX) Stock - Defense World
Vaccinex sees insider purchase worth over $55k by FCMI Parent Co. - Investing.com India
Vaccinex sees insider purchase worth over $55k by FCMI Parent Co. - Investing.com Canada
Vaccinex Inc Stock (VCNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):